Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIVI-10: Ocriplasmin PK prior to Vitrectomy
NCT01159665Phase 2Completed
- Sponsor
- Oxurion
- Start
- Jul 2010
- Primary completion
- Nov 2010
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ocriplasmin in vitreomacular adhesion (VMA), vitreomacular traction (VMT), sponsored by Oxurion. Started Jul 2010; status: completed.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular adhesion (VMA)vitreomacular traction (VMT)
Beyond the preview
Go deeper on NCT01159665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159665.